Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,46 USD | -0,24% | +8,21% | +26,31% |
30/04 | Alvotech gaat Humira Biosimilar Adalimumab-ryvk maken voor Quallent | MT |
25/04 | Cigna gaat Humira rivalen aanbieden met $0 copay bij gespecialiseerde apotheek | RE |
Vakgebied
Aantal werknemers: 999
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biosimilar Medicines
100,0
%
| 83 | 100,0 % | 91 | 100,0 % | +10,12% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Europe
69,5
%
| 39 | 47,5 % | 64 | 69,5 % | +61,06% |
North America
20,0
%
| 31 | 37,1 % | 18 | 20,0 % | -40,53% |
Asia and Other
10,5
%
| 0 | 0,0 % | 10 | 10,5 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vilhelm Wessman
CEO | Chief Executive Officer | 54 | 02-11-18 |
Joel Morales
DFI | Director of Finance/CFO | 46 | 01-02-20 |
Giedrius Zunda
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-23 |
Chief Tech/Sci/R&D Officer | 50 | 01-10-19 | |
Faysal Kalmoua
COO | Chief Operating Officer | 48 | 01-06-20 |
Investor Relations Contact | - | 02-03-22 | |
Ming Li
PRN | Corporate Officer/Principal | 47 | - |
Anil Okay
PRN | Corporate Officer/Principal | 38 | - |
Helga Zharov
LAW | General Counsel | 57 | 01-05-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Linda McGoldrick
BRD | Director/Board Member | 68 | 16-06-22 |
Helga Zharov
LAW | General Counsel | 57 | 01-05-20 |
Vilhelm Wessman
CEO | Chief Executive Officer | 54 | 02-11-18 |
Tomas Ekman
BRD | Director/Board Member | 56 | 01-01-19 |
Richard Davies
BRD | Director/Board Member | 62 | 01-01-19 |
Árni Harðarson
BRD | Director/Board Member | 57 | 16-06-22 |
Lisa Graver
BRD | Director/Board Member | 53 | 16-06-22 |
Faysal Kalmoua
COO | Chief Operating Officer | 48 | 01-06-20 |
Ann Merchant
BRD | Director/Board Member | 59 | 16-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 266 821 844 | 72 673 643 ( 27,24 %) | 0 | 27,24 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,31% | 4,05 mld. | |
-0,26% | 42,19 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+5,44% | 24,63 mld. | |
-23,59% | 18,2 mld. | |
+26,39% | 12,01 mld. | |
-3,24% | 11,76 mld. | |
+12,94% | 10,4 mld. | |
-4,06% | 9,94 mld. |
- Beurs
- Aandelen
- Koers ALVO
- Onderneming Alvotech